Hans Lilja
241 – 250 of 455
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Testing new PSA subforms to enhance the accuracy of predicting cancer risk and disease outcome in prostate cancer
(
- Contribution to journal › Article
-
Mark
Serum Markers for Prostate Cancer : A Rational Approach to the Literature
(
- Contribution to journal › Scientific review
-
Mark
Screening for prostate cancer : an update.
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
(
- Contribution to journal › Article
-
Mark
Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective
(
- Contribution to journal › Article
-
Mark
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section
(
- Contribution to journal › Article
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article
-
Mark
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
(
- Contribution to journal › Article